Tafenoquine Chemical Structure Clean (Krintafel Spl Graphic 01)
Krintafel Tablet, Film Coated
Product Images NDC 0173-0889
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Krintafel (NDC 0173-0889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Krintafel 150 mg 30 Count Label (Krintafel Spl Graphic 02)
This is a description of a medication called Krintafel with the active ingredient tafenoquine. Each tablet contains 150mg of the medication. It is a prescription-only medication and should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be kept in its original package and protected from moisture. The tablets should not be broken or crushed. The medication is manufactured by GlaxoSmithKline, located in Research Triangle Park, NC 27709, and the tablets are made in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
